Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05106036 · ClinicalTrials.gov registry record · NA

Preventing Cognitive Decline by Reducing BP Target Trial

A NA study of Hypertension and Blood Pressure, sponsored by University of Texas Southwestern Medical Center.

Recruiting
Registry status
NA
Development phase
4,000
Enrollment target
1
Study location

NCT05106036: Recruiting NA study of Hypertension and Blood Pressure, sponsored by University of Texas Southwestern Medical Center.

NCT05106036 is a NA study of Hypertension and Blood Pressure that is actively recruiting participants, run by University of Texas Southwestern Medical Center. The registered enrollment target is 4,000 participants, above the 3,499-participant average among 470 other Hypertension trials with a reported enrollment target (14% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05106036, a NA study of Hypertension and Blood Pressure, is actively recruiting participants, sponsored by University of Texas Southwestern Medical Center.

RECRUITING
Registry status
NA
Development phase
4,000 participants
Enrollment target
1
Study location

Study Summary

The PCOT study is a multi-site randomized trial of patients 70 years or older with high BP. The main goal of the study Preventing Cognitive Decline by Reducing BP Target Trial (PCOT) is to conduct a large pragmatic clinical trial (PCT) to test the hypothesis that patients who receive care with a combination of clinical decision support (CDS) and team-based care delivered in primary care practices will have better blood pressure control and a lower incidence of mild cognitive impairment and dementia than patients receiving usual medical care. Patients will be recruited from UT Southwestern Medical Center and Parkland Health \& Hospital System.

Primary Outcome

Rate of change in Modified Telephone Interview for Cognitive Status (TICS-m) test between study arms. The test has scores ranging from 0 to 42 with higher values indicating better cognitive status.

Interventions

  • OTHER Clinical Support Decision Tool

Study Locations (1)

Texas

  • UT Southwestern Medical Center - Dallas

Trial Details

FieldValue
Enrollment Target 4,000 participants
Start Date 2022-07-11
Est. Completion 2026-08-31
Phase NA

What NCT05106036 shows while recruiting

NCT05106036 is an interventional study that assigns participants to a tested intervention. Its 4,000 participants enrollment target places it among the larger protocols in the corpus, above the 3,499-participant average among 470 other Hypertension trials with a reported enrollment target (14% higher).

The record links to 3 conditions, with Hypertension appearing as the primary indexed condition, and to 1 intervention - of which Clinical Support Decision Tool is the first listed.

NCT05106036 reports a single indexed study location in Texas.

Frequently Asked Questions

What is clinical trial NCT05106036 about?

NCT05106036 is a clinical study titled "Preventing Cognitive Decline by Reducing BP Target Trial". The PCOT study is a multi-site randomized trial of patients 70 years or older with high BP. The main goal of the study Preventing Cognitive Decline by Reducing BP Target Trial (PCOT) is to conduct a large pragmatic clinical trial (PCT) to test the hypothesis that patients who receive care with a com...

What is the current status of trial NCT05106036?

This trial is currently recruiting. It is a NA study. The enrollment target is 4,000 participants. The study started on 2022-07-11. Estimated completion is 2026-08-31.

What conditions does trial NCT05106036 study?

This clinical trial studies the following conditions: Hypertension, Blood Pressure, Cognitive Decline.

What interventions are being tested in trial NCT05106036?

The interventions under investigation include: Clinical Support Decision Tool (OTHER).

Who is sponsoring clinical trial NCT05106036?

This trial is sponsored by University of Texas Southwestern Medical Center, which has 837 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05106036 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Hypertension

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05106036's enrollment target sits among peer trials

4,000 34th of 470 higher than 437 of 470 other Hypertension trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Hypertension trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00227253 · 4,000 participants

    Chromosome 18 Clinical Research Center

  • NCT00811148 · 4,000 participants

    Florida Center for Brain Tumor Research

  • NCT00897117 · 4,000 participants

    Collecting and Analyzing Tissue Samples From Patients Undergoing Surgery for Non-Small Cell Lung Cancer

  • NCT00899301 · 4,000 participants

    Collecting and Storing Tissue Samples From Women With or Without Breast Cancer

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05106036, the US trial registry maintained by the National Library of Medicine. NCT05106036 (large enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.